Skip to main content

Table 1 Sample characteristics

From: MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study

 

Total

Male

Female

N = 12

n = 8

n = 4

Demographics

Age

 Mean (± SD)

31.33 (2.84)

31.13 (3.44)

31.75 (1.26)

 [Range] years

[26–36]

[26–36]

[25–33]

Ethnicity, n (%)

 White

11 (91.7)

7 (87.5)

4 (100)

 Other

1 (8.3)

1 (12.5)

0 (0)

Marital status, n (%)

 Single, never married

10 (83.3)

6 (75.0)

4 (100)

 Married

2 (16.7)

2 (25.0)

0 (0)

Education, n (%)

 Some high school

3 (25.0)

3 (37.5)

0 (0)

 High school graduate or GED

5 (41.7)

3 (37.5)

2 (50.0)

 Some college or trade school

4 (33.3)

2 (25.0)

2 (50.0)

Employment, n (%)

 Employed

7 (58.3)

6 (75.0)

1 (25.0)

 Unemployed

5 (41.7)

2 (25.0)

3 (75.0)

Comorbid mental health disorder

Depression, n (%)

 Hx major depressive episode

5 (41.7)

3 (37.5)

2 (50.0)

Anxiety, n (%)

 Any anxiety disorder

7 (58.3)

4 (50.0)

3 (75.0)

PTSD, n (%)

 Subset of anxiety

3 (25.0)

2 (25.0)

1 (25.0)

Recent illicit substance use

Cocaine, n (%)

 30 days prior to baseline

4 (33.3)

4 (50.0)

0 (0)

Benzodiazepines, n (%)

 30 days prior to baseline

7 (58.3)

3 (37.5)

4 (100)

Technology use

Videoconference, n (%)

 Any use before study

4 (33.3)

4 (50.0)

0 (0)

Smartphone, n (%)

 Any use before study

12 (100)

8 (100)

4 (100)